Ícone da app AgingResearch.News: Longevity

The fastest way to know what really works in longevity

Por PAPERFOOT AI PTE. LTD. · Social
Pontuação Debuts 76NovaSê o primeiro a avaliar

Porque esperamos isto: Clear, well-documented value for longevity researchers, with evidence-focused descriptions and useful follow and alert features.

Captura de ecrã 1 de AgingResearch.News: LongevityCaptura de ecrã 2 de AgingResearch.News: LongevityCaptura de ecrã 3 de AgingResearch.News: LongevityCaptura de ecrã 4 de AgingResearch.News: LongevityCaptura de ecrã 5 de AgingResearch.News: Longevity

Apps de Social semelhantes

Ver as melhores

Em resumo

AgingResearch.News: Longevity scans ageing research papers from sources such as PubMed and bioRxiv, summarises their findings in plain English with citations, and ranks them on evidence. It suits people following longevity science, including researchers, who can follow topics and export references to Zotero, EndNote or Mendeley. It stands out for showing, at a glance, what was studied, in which subjects, and the catch.

Resumo do Debuts, com base na ficha da App Store.

Sobre

The fastest way to know what really works in longevity.

AgingResearch.News scans the world’s ageing research in real time: 1,800+ papers an hour from PubMed, bioRxiv, medRxiv, arXiv, Europe PMC and journals worldwide. It reads every one, weighs the evidence and tells you what it found in plain English, with every claim cited. Over 690,000 papers so far.

NEVER MISS A BREAKTHROUGH The papers that matter, ranked on evidence, never on fame. What was studied, in whom, what changed, and the catch, at a glance. Mouse, cell or human: you see it instantly.

FOLLOW WHAT YOU CARE ABOUT Follow a drug, gene, pathway, disease, lab or author, and get an alert the moment a new paper on it lands. Rapamycin, senolytics, NAD+, metformin, GLP-1s, epigenetic clocks, reprogramming: thousands of subjects, each with an evidence profile from cells and mice to human trials.

ASK THE LITERATURE Ask anything about ageing research and get an answer in seconds, drawn from the papers, with the sources to check.

SEE THE FIGURES Every paper’s own figures, a tap away. Save papers to read later, on your phone and on the web.

PLUS For you: your field, ranked for your own research, with a match score on every paper. 20 questions a day to Ask, 5 interests and 25 follows, each with its own alerts, and export to Zotero, EndNote or Mendeley. One subscription works in the app and on agingresearch.news.

PRO Everything in Plus, with 500 questions a day to Ask, 25 interests, unlimited follows and 10 email digests. On agingresearch.news: company profiles, asset records, dashboards, watchlists and the catalyst calendar, 25 Ultradeep reviews a day, due-diligence packs, and the API and MCP server.

Plus and Pro renew automatically unless cancelled at least 24 hours before the period ends. Manage or cancel them in your Apple Account settings.

Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/ Terms: https://agingresearch.news/terms Privacy: https://agingresearch.news/privacy

Perguntas sobre AgingResearch.News: Longevity

O que é AgingResearch.News: Longevity?
AgingResearch.News: Longevity scans ageing research papers from sources such as PubMed and bioRxiv, summarises their findings in plain English with citations, and ranks them on evidence. It suits people following longevity science, including researchers, who can follow topics and export references to Zotero, EndNote or Mendeley. It stands out for showing, at a glance, what was studied, in which subjects, and the catch.
AgingResearch.News: Longevity é gratuita?
Sim. AgingResearch.News: Longevity é gratuita para descarregar.
Em que dispositivos funciona AgingResearch.News: Longevity?
AgingResearch.News: Longevity funciona em iPhone, iPad.
Em que idiomas está AgingResearch.News: Longevity disponível?
AgingResearch.News: Longevity está disponível em 11 idiomas, incluindo alemão, inglês, espanhol, francês, italiano, japonês.
Quem criou AgingResearch.News: Longevity?
AgingResearch.News: Longevity é criada por PAPERFOOT AI PTE. LTD.. A classificação etária na App Store é 12+.
Quais são as alternativas a AgingResearch.News: Longevity?
Apps semelhantes no Debuts: Chaluu: Accessible Messaging, Vigia Brasília, Fanfold: News as Magazines.

A avaliação das pessoas

Inicia sessão para avaliares esta aplicação. O que conta é seres sincero.

Ainda sem avaliações. Já a experimentaste? Sê o primeiro a avaliar.

Sinais de descoberta

Como a IA e as pessoas descobrem AgingResearch.News: Longevity no Debuts
Pronta para IAEm parte
78% descrita para a IA a associar
Descobrível agoraAtivaDados estruturados nesta página e a API do Debuts

Diz-nos do que gostas. Só enviamos e-mail quando surge algo novo que corresponda, e os criadores costumam acrescentar uma oferta para testadores.

Que tipo de apps
No meu
Mostrar só
Com que frequência
Enviamos um link de confirmação. Não recebes nada até clicares nele.